Wednesday, March 29, 2017 9:25:05 AM
Ha! Glad I'm not the only one :) I've raged. I'm sure the company thinks I'm totally bipolar lol. I've wondered myself at times lol
Going forward I'm going to try to be better behaved lol
It's the SILENCE that has killed me slowly. I don't really care about the dilution. Like ES1 said, it's been kept at a minimum, relatively speaking and when they start making mad money they can buy back shares. I also haven't cared a whole lot about the share price except when I'm buying and then it goes lower lol.
Nope, it's the silence that has made me rage. The lack of cc's etc. You all know how I feel, I won't get into all that again. Hopefully better communication is in our future. This last PR was an excellent example of not only good pr, but good communication. As some other poster pointed out, this time they told us exactly where they stood, that they still needed the central government's approval. That's the kind of thing I want to hear about :) Gimme the bad, not just the good :)
I've gotten zero sleep. I am daydreaming about kblb and it's keeping me awake. I keep saying I'm not going to post anymore but like a moth to a flame....
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM